scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0735-1097(01)01724-7 |
P698 | PubMed publication ID | 11788212 |
P50 | author | Steven E. Reis | Q47700105 |
Michael Terrin | Q60057985 | ||
P2093 | author name string | Steven P Schulman | |
Sandra Forman | |||
Steven E Reis | |||
Pamela Ouyang | |||
Gary Gerstenblith | |||
Raymond D Bahr | |||
David R Thiemann | |||
Susan N Townsend | |||
Cicero Piva de Albuquerque | |||
Douglas S Schulman | |||
Nisha C Chandra | |||
Rosalie Cosgriff | |||
P2860 | cites work | Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
The protective effects of estrogen on the cardiovascular system | Q33654314 | ||
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women | Q34067367 | ||
17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease | Q34313559 | ||
Estrogen acutely abolishes abnormal cold-induced coronary constriction in men. | Q34485489 | ||
Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants | Q34504289 | ||
Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms | Q34507733 | ||
Cardiovascular health and disease in women | Q40818333 | ||
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators | Q42606103 | ||
"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients | Q43457132 | ||
Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina | Q43662118 | ||
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study | Q43788768 | ||
Designs for group sequential tests. | Q52684721 | ||
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. | Q54202553 | ||
Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. | Q54217834 | ||
Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients | Q68195411 | ||
Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina | Q69400976 | ||
Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina | Q69881024 | ||
Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators | Q69936133 | ||
Vasoreactivity of the culprit lesion in unstable angina | Q72047906 | ||
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease | Q72225668 | ||
Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women | Q72344096 | ||
Human vascular smooth muscle cells contain functional estrogen receptor | Q72415115 | ||
Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys | Q72811876 | ||
Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system | Q73311903 | ||
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women | Q73794024 | ||
The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women | Q73914741 | ||
Short-term anti-ischemic effect of 17beta-estradiol in postmenopausal women with coronary artery disease | Q73914755 | ||
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial | Q73965928 | ||
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis | Q74212886 | ||
Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function | Q74505515 | ||
Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women | Q77319712 | ||
Studies of acute coronary syndromes in women--lessons for everyone | Q78021962 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 231-237 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina | |
P478 | volume | 39 |
Q78578643 | Acute haemodynamic effects of oestrogen administration in male patients with chronic heart failure |
Q35060438 | American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease--the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. |
Q37180867 | Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity? |
Q44439753 | Effect of Short-Term estrogen with and without progesterone therapy on circulating markers of endothelial activation and injury in postmenopausal women with unstable angina pectoris |
Q73143247 | Estrogen administration in patients with chronic heart failure: not ready for prime time |
Q43852478 | Estrogen therapy for unstable angina: another bump for the bandwagon |
Q37427243 | Gender differences in coronary artery disease: review of diagnostic challenges and current treatment |
Q44620741 | Hormonal replacement therapy and cardiovascular risk: contra-indication or non-indication? |
Q74490958 | Hormone replacement therapy |
Q24244146 | Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women |
Q43873735 | Hormone replacement therapy trials: an update |
Q78724442 | Hormones for coronary disease-full circle |
Q46209142 | Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis |
Q33644735 | Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations |
Q94324633 | Menopause |
Q35561539 | Mental health issues associated with cardiovascular disease in women |
Q43436671 | Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial |
Q34774237 | Postmenopausal hormone replacement therapy and atherosclerosis. |
Q35692889 | Postmenopausal hormone therapy: a concise guide to therapeutic uses, formulations, risks, and alternatives |
Q36103091 | ST-segment analysis in ambulatory ECG (AECG or Holter) monitoring in patients with coronary artery disease: clinical significance and analytic techniques. |
Q55094602 | Sex and cardiovascular disease status differences in attitudes and willingness to participate in clinical research studies/clinical trials. |
Q34834758 | The overselling of hormone replacement therapy |
Q49477839 | Yoga Offers Cardiovascular Protection in Early Postmenopausal Women |
Search more.